Leniolisib Phosphate

CHEMBL3989909 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

548.5 g/mol

LogP

—

Phase

4

The phosphate salt form of leniolisib, a PI3K-delta inhibitor studied for treating primary immunodeficiency disorders. It shares the same targeted mechanism as the parent compound.

Masse moléculaire

548,5000 g/mol

TPSA

161,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1.O=P(O)(O)O

InChI

InChI=1S/C21H25F3N6O2.H3O4P/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14;1-5(2,3)4/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28);(H3,1,2,3,4)/t13-;/m0./s1

Molecular Formula

C21H28F3N6O6P

HBD / HBA

4 / 14

Liaisons Rotatives

5

Atomes Lourds

37

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

The phosphate salt form of leniolisib, a PI3K-delta inhibitor studied for treating primary immunodeficiency disorders. It shares the same targeted mechanism as the parent compound.

Yes, Leniolisib Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989909. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 90214495. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Leniolisib Phosphate sur PillFYI

Structure

Données Clés

Formule: C21H28F3N6O6P

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.